Jiménez-Cortegana, C., Salar, A., & Cruz-Merino, L. (2021). Circulating myeloid-derived suppressor cells and regulatory T cells as immunological biomarkers in refractory/relapsed diffuse large B-cell lymphoma: Translational results from the R2-GDP-GOTEL trial.
Citación estilo ChicagoJiménez-Cortegana, Carlos, Antonio Salar, y Luis Cruz-Merino. Circulating Myeloid-derived Suppressor Cells and Regulatory T Cells As Immunological Biomarkers in Refractory/relapsed Diffuse Large B-cell Lymphoma: Translational Results From the R2-GDP-GOTEL Trial. 2021.
Cita MLAJiménez-Cortegana, Carlos, Antonio Salar, y Luis Cruz-Merino. Circulating Myeloid-derived Suppressor Cells and Regulatory T Cells As Immunological Biomarkers in Refractory/relapsed Diffuse Large B-cell Lymphoma: Translational Results From the R2-GDP-GOTEL Trial. 2021.